The assay integrates biological information tracking immune response, luminal differentiation, tumor cell proliferation and expression of the HER2 17q12-21 chromosomal amplicon, including the ERBB2 gene, with clinical information (i.e., tumor size and nodal status) [17]. The gene discussed is ERBB2; the disease is neoplasm.